Investigation of the Optimal Treatment Strategy for Atrial Fibrillation in Japan-The J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Study Design-

DOI Web Site PubMed 39 Citations 20 References

Bibliographic Information

Other Title
  • The J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Study Design

Search this article

Description

The Japanese Rhythm Management Trial for Atrial Fibrillation (J-RHYTHM study) is a randomized comparative evaluation of rate control and rhythm control, both combined with antithrombotic therapy, as therapeutic strategies for the treatment of atrial fibrillation (AF). This study differs from the earlier AFFIRM and RACE studies in that it has a composite primary end-point representing mortality and also physical/psychological disablement (total mortality, symptomatic cerebral infarction, systemic embolism, major bleeding, hospitalization for heart failure requiring intravenous administration of diuretics, and patient disablement). Patients' will to change the therapeutic strategy to the other is also considered as an end-point representing disablement under the assigned strategy. The secondary end-point includes quality of life scores and the efficacy and safety of drugs used in treating AF. The J-RHYTHM study emphasizes patient-reported experience and perception of AF-specific disablement, and the safety of antiarrhythmics available in Japan; it will follow 2,600 patients treated at more than 150 sites in Japan for a 3-year period. (Circ J 2003; 67: 738 - 741)<br>

Journal

  • Circulation Journal

    Circulation Journal 67 (9), 738-741, 2003

    The Japanese Circulation Society

Citations (39)*help

See more

References(20)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top